Skip to content
Triangle logo TriangleGet started
← All settings

DISEASE & TREATMENT SETTING

Germ Cell Tumor

Source-derived catalogue. This is not a treatment recommendation or a personalised trial match.

Exact scope

Germ Cell Tumor

Source population
Not part of this definition
Disease extent
Not part of this definition
Treatment line
Not part of this definition
Stage
Not part of this definition
Resectability
Not part of this definition
Biomarkers, prior therapy and derivation
molecular
    prior therapy
      derivation status
      source-attested
      derivation note
      Added because the terminology and the registry both attest it: an NCIt neoplasm concept named by 6 acquired study condition(s). It is absent from the NCI treatment-topic directory, which is not an exhaustive cancer inventory.
      source wording
      Source null

      Study evidence for this setting

      10 linked studies · Applicability is a draft source assessment, not a determination of your eligibility.

      NCT00183820 · Registry condition search · Scope: narrower

      Study of Gemcitabine, Oxaliplatin, and Paclitaxel in Patients With Refractory Germ Cell Carcinoma

      3 outcome links · 1 safety-group records · 0 quality-of-life measures

      →

      NCT00492089 · Registry condition search · Scope: narrower

      Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer

      1 outcome links · 2 safety-group records · 0 quality-of-life measures

      →

      NCT00957905 · Registry condition search · Scope: narrower

      Alvocidib and Oxaliplatin With or Without Fluorouracil and Leucovorin Calcium in Treating Patients With Relapsed or Refractory Germ Cell Tumors

      4 outcome links · 2 safety-group records · 0 quality-of-life measures

      →

      NCT01037790 · Registry condition search · Scope: narrower

      Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer

      1 outcome links · 5 safety-group records · 0 quality-of-life measures

      →

      NCT01808534 · Registry condition search · Scope: narrower

      Palifosfamide in Treating Patients With Recurrent Germ Cell Tumors

      5 outcome links · 1 safety-group records · 0 quality-of-life measures

      →

      NCT02162732 · Registry condition search · Scope: narrower

      Molecular-Guided Therapy for Childhood Cancer

      4 outcome links · 1 safety-group records · 0 quality-of-life measures

      →

      NCT02499952 · Registry condition search · Scope: narrower

      Pembrolizumab in Subjects With Incurable Platinum-Refractory Germ Cell Tumors

      4 outcome links · 1 safety-group records · 0 quality-of-life measures

      →

      NCT02689219 · Registry condition search · Scope: narrower

      Brentuximab Vedotin in Relapsed/Refractory Germ Cell Tumors

      4 outcome links · 2 safety-group records · 0 quality-of-life measures

      →

      NCT02721732 · Registry condition search · Scope: narrower

      Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic

      6 outcome links · 1 safety-group records · 0 quality-of-life measures

      →

      NCT04283773 · Registry condition search · Scope: narrower

      Immunohistochemical Evaluation of Protein P16 Expression in Ovarian Germ Cell Tumors.

      3 outcome links · 3 safety-group records · 0 quality-of-life measures

      →
      Source relationships and population-mapping limitations
      bindings
      1. release id
        clinical-indications-draft-1
        disease state id
        ds-germ-cell-tumor
        binding id
        ncit-C3708
        source collection
        ncit-concept
        source key
        C3708
        source excerpt
        Source null
        match status
        exact
        match note
        Source null
        recorded at
        2026-09-10T00:00:00Z
      mappings

        Download this complete draft source relationship record →

        Preserved source evidence · Not medical advice